The Lancet Haematology in conversation with
Total duration:
9 h 19 min
Sabine Braat and Katherine Fielding on haemoglobin thresholds to define anaemia
The Lancet Haematology in conversation with
18:06
Elisabeth Schorb on the MARTA phase 2 trial
The Lancet Haematology in conversation with
09:23
Stephan Ehl on paediatric autoimmune lymphoproliferative immunodeficiencies
The Lancet Haematology in conversation with
13:03
Dr Sarah O'Brien on the PREVAPIX-ALL trial
The Lancet Haematology in conversation with
13:50
Enrico Lopriore on haemolytic disease of the fetus and newborn
The Lancet Haematology in conversation with
12:33
Meletios Dimopoulos on relapsed and refractory multiple myeloma
The Lancet Haematology in conversation with
11:00
Eric Ohuma on haemoglobin concentrations and neonatal outcomes
The Lancet Haematology in conversation with
16:27
Margaret Ragni on tranexamic acid to treat heavy menstrual bleeding
The Lancet Haematology in conversation with
13:13
Oreofe Odejide and Thomas Kuczmarski on mental health and lymphoma
The Lancet Haematology in conversation with
16:32
Alok Srivastava on fitusiran for patients with haemophilia A and B
The Lancet Haematology in conversation with
18:41
Emmanuela E Ambrose on stroke prevention in children with sickle cell disease
The Lancet Haematology in conversation with
11:31
Sumit Gupta on racial and ethnic disparities in leukaemia survival outcomes
The Lancet Haematology in conversation with
22:10
Xiao-Jun Huang on cellular therapy in China
The Lancet Haematology in conversation with
28:10
Glenn Pierce on haemophilia care in LMICs
The Lancet Haematology in conversation with
34:55
Amy DeZern on the link between myelodysplastic syndrome and autoimmune disorders
The Lancet Haematology in conversation with
12:50
Nicholas Crombie and Gavin Perkins on resuscitation with blood products compared with saline
The Lancet Haematology in conversation with
15:05
Fredrik Schjesvold on OCEAN phase 3
The Lancet Haematology in conversation with
12:24
Jacob D Soumerai and Andrew D Zelenetz on the BOVen regimen for previously untreated patients with chronic lymphocytic leukaemia
The Lancet Haematology in conversation with
11:59
Raul Cordoba on haematological malignancies in older people
The Lancet Haematology in conversation with
16:24
Obiageli Nnodu and Dennis Chao on child mortality from sickle cell disease in Nigeria
The Lancet Haematology in conversation with
09:03
Zuguo Mei and Gary Brittenham on iron deficiency
The Lancet Haematology in conversation with
08:34
Eugenia Trigoso Arjona (in Spanish) on nursing and haematological care
The Lancet Haematology in conversation with
29:11
Eugenia Trigoso Arjona (in English) on nursing and haematological care
The Lancet Haematology in conversation with
28:34
Nada Hamad on inclusion and diversity in haematology
The Lancet Haematology in conversation with
30:02
Dr Judith Boer on lymphoblastic leukaemia in children
The Lancet Haematology in conversation with
10:24
Imatinib for paediatric leukaemia
The Lancet Haematology in conversation with
08:33
Predicting the risk of adenoviraemia
The Lancet Haematology in conversation with
04:51
Adverse events in haematological malignancies
The Lancet Haematology in conversation with
12:31
EPO blood doping and cycling: The Lancet Haematology: June 29, 2017
The Lancet Haematology in conversation with
08:34
Trauma-induced coagulopathy: The Lancet Haematology: June issue
The Lancet Haematology in conversation with
09:10
Childhood leukaemia survival (CONCORD-2): The Lancet Haematology: April 11, 2017
The Lancet Haematology in conversation with
05:46
Superficial-vein thrombosis: The Lancet Haematology: February 15 2017
The Lancet Haematology in conversation with
10:27
Economic burden of blood disorders in Europe: The Lancet Haematology: July 21, 2016
The Lancet Haematology in conversation with
09:32
Castleman disease: The Lancet Haematology: March 17, 2016
The Lancet Haematology in conversation with
17:14
Deep-vein thrombosis: The Lancet Haematology, October 29, 2015
The Lancet Haematology in conversation with
08:23
Financial toxicity: The Lancet Haematology: September 17, 2015
The Lancet Haematology in conversation with
06:06
Idiopathic thrombocytopenic purpura: The Lancet Haematology: July 29, 2015
The Lancet Haematology in conversation with
06:24
INWORKS: The Lancet Haematology: June 29, 2015
The Lancet Haematology in conversation with
06:36
Warfarin: The Lancet Haematology: May 26, 2015
The Lancet Haematology in conversation with
12:05
Atrial fibrillation and NOACs: The Lancet Haematology: April 2, 2015
The Lancet Haematology in conversation with
09:12